Browsing Category
Drug research
Eli Lilly to launch weight loss drug in UK ‘within a few weeks’
Mounjaro, a weight-loss drug that is available in an injectable pen in Great Britain in the near future for the treatment of diabetes and obesity will be made available by Eli Lilly after the UK medicines regulator approved its sale on…
Data shows that expired Pfizer Covid antiviral medications will cost Europe $2.2bn.
According to data from the European Health Agency, more than one billion dollars of Pfizer Covid-19 antiviral medications procured by Pfizer in Europe were wasted because strict controls on who could receive the medication led to millions…
Syntara’s $10M Raise: Fueling Drug Development
Syntara's $10M capital raise is propelling its drug development strategy into a new era.
In this exclusive interview, CEO Gary Phillips unveils the transformative steps taken by Syntara Ltd, from its rebranding efforts to the strategic…
AstraZeneca acquires US vaccine company for $1.1bn
AstraZeneca has acquired its first vaccine company for $1.1bn. This will allow the company to expand its vaccine and immunotherapy business, which it established during the Covid pandemic.
The largest drugmaker in Britain has agreed to…
Weight loss drug manufacturer plots a ‘buy Now, Pay Later’ offer
Novo Nordisk wants to help more people get Wegovy jabs, including those who are currently unable to access them.
Novo Nordisk, a maker of obesity drugs, said that it would offer countries the option to "buy now and pay later" for its…
AstraZeneca defends its Covid-19 injection against accusations that it was defective
AstraZeneca has contested accusations that the Covid-19 vaccine was "defective", after a vaccine patient sued for damages, claiming to have suffered a severe side-effect.
The Anglo-Swedish pharmaceutical company, which developed the…